Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.

[1]  A. Schmaier,et al.  Identification and Characterization of Prolylcarboxypeptidase as an Endothelial Cell Prekallikrein Activator* , 2002, The Journal of Biological Chemistry.

[2]  A. Kaplan,et al.  Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Renné,et al.  High Molecular Weight Kininogen Utilizes Heparan Sulfate Proteoglycans for Accumulation on Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[4]  R. Colman,et al.  Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin. , 2000, Biochemistry.

[5]  A. Kaplan,et al.  Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. , 1999, Clinical immunology.

[6]  A. Schmaier,et al.  Factor XII Does not Initiate Prekallikrein Activation on Endothelial Cells , 1998, Thrombosis and Haemostasis.

[7]  A. Schmaier,et al.  High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. , 1998, Blood.

[8]  R. Colman,et al.  Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. , 1997, The Journal of clinical investigation.

[9]  E. Peerschke,et al.  Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Schmaier,et al.  Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 (*) , 1995, The Journal of Biological Chemistry.

[11]  S. Reddigari,et al.  Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. , 1993, The Journal of biological chemistry.

[12]  P. Kuna,et al.  Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. , 1993, Blood.

[13]  A. Schmaier,et al.  High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. , 1992, Blood.

[14]  A. Schmaier,et al.  Human neutrophils contain and bind high molecular weight kininogen. , 1989, The Journal of clinical investigation.

[15]  A. Schmaier,et al.  The expression of high molecular weight kininogen on human umbilical vein endothelial cells. , 1988, The Journal of biological chemistry.

[16]  P. D. de Groot,et al.  The binding of high molecular weight kininogen to cultured human endothelial cells. , 1988, The Journal of biological chemistry.

[17]  S. Higashiyama,et al.  Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies. , 1987, Biochemistry.

[18]  A. Schmaier,et al.  High molecular weight kininogen binds to unstimulated platelets. , 1986, The Journal of clinical investigation.

[19]  M. Kunimatsu,et al.  Human high molecular weight kininogen as a thiol proteinase inhibitor: presence of the entire inhibition capacity in the native form of heavy chain. , 1986, Biochemistry.

[20]  V. Turk,et al.  Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. , 1985, FEBS letters.

[21]  J. Griffin,et al.  Receptors for high molecular weight kininogen on stimulated washed human platelets. , 1984, Biochemistry.

[22]  J. Finlayson,et al.  Kinetics of activation and autoactivation of human factor XII. , 1984, Biochemistry.

[23]  E. Jaffe.  SYNTHESIS OF FACTOR VIII BY ENDOTHELIAL CELLS , 1982, Annals of the New York Academy of Sciences.

[24]  Jaffe Ea,et al.  Culture of human endothelial cells. , 1980, Transplantation proceedings.

[25]  J. Dunn,et al.  Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.

[26]  J. Griffin,et al.  Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. , 1979, The Journal of biological chemistry.

[27]  A. Kaplan,et al.  Association of factor XI and high molecular weight kininogen in human plasma. , 1977, The Journal of clinical investigation.

[28]  J. Griffin,et al.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Colman,et al.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. , 1977, The Journal of clinical investigation.

[30]  R. Colman,et al.  Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Griffin,et al.  Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Markus,et al.  Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex. , 1972, The Journal of biological chemistry.

[33]  P. H. Bell,et al.  The mechanism of activation of human plasminogen by streptokinase. , 1971, Biochemical and biophysical research communications.

[34]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[35]  A. Kaplan,et al.  Factor XII-dependent Contact Activation on Endothelial Cells and Binding Proteins gC1qR and Cytokeratin 1 , 2001, Thrombosis and Haemostasis.

[36]  H. Herwald,et al.  Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. , 2001, European journal of biochemistry.

[37]  J. Griffin,et al.  Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. , 1980, The Journal of clinical investigation.